# Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

> **NCT00005851** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer

## Interventions

- **DRUG:** fludarabine phosphate
- **RADIATION:** total-body irradiation
- **PROCEDURE:** nonmyeloablative allogeneic hematopoietic stem cell transplantation
- **DRUG:** cyclosporine
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** peripheral blood stem cell transplantation
- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00005851
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2004-07
- **Final completion:** 2018-09-27
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005851, "Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00005851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*